News | May 09, 2007

Cedara, Varian Pen Licensing Agreement

May 10, 2007 - Cedara Software, a Merge Healthcare company, announced it has concluded a licensing agreement with Varian Medical Systems, giving Varian exclusive global rights to distribute Cedara’s I-Response technology within the radiation and medical oncology market.
Cedara I-Response is a tool that analyzes how cancerous tumors are responding to treatment. I-Response supports multiple imaging modalities and features patented analysis of fDM (Functional Diffusion Mapping) MR images. It allows professionals to visualize and quantify changes in tumor tissue resulting from cellular and metabolic mechanisms, and then track the data over time. In this way, Cedara I-Response has the potential to precisely monitor the impact of anti-cancer drugs and radiation therapy early in the course of treatment, adding to the information that clinicians can reference when developing personalized treatment plans.
Cedara I-Response complements Varian’s Dynamic Adaptive Radiation Therapy (DART) program with its image analysis capabilities that assist oncologists in making treatment decisions for their patients. Cedara I-Response has received FDA 510k clearance and the company expects a commercial release in June 2007.

Related Content

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

Feature | Clinical Decision Support | January 18, 2018
January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader
News | Clinical Decision Support | January 12, 2018
January 12, 2018 — GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop an
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Mirada Medical and Optellum Debut AI-Based Lung Cancer Diagnosis Solution at RSNA 2017
News | Computed Tomography (CT) | December 14, 2017
Optellum, a high-tech startup in lung cancer and machine learning, and Mirada Medical recently announced a partnership...
HealthMyne Highlights Value of Quantitative Data in Oncology Reads at RSNA 2017
News | Clinical Decision Support | November 17, 2017
November 17, 2017 — At the 2017 Radiological Society of North America (RSNA) conference, HealthMyne will demonstrate
Intelerad Announces Partnership With MedCurrent
News | Clinical Decision Support | November 13, 2017
November 13, 2017 — Intelerad Medical Systems announced a partnership that will see MedCurrent’s OrderWise...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
HealthMyne QIDS 3.0 Platform Addresses Incidental Findings Workflow
Technology | PACS Accessories | October 18, 2017
October 18, 2017 — HealthMyne announced the release of QIDS (Quantitative Imaging Decision Support) 3.0 with the Inci
Appropriate Use Criteria Published for Valvular Heart Disease Imaging Tests
News | Clinical Decision Support | October 16, 2017
The American College of Cardiology (ACC), along with several partnering societies, recently released appropriate use...
ACR Appropriateness Criteria Add Topics, Increase Diagnostic Imaging Clinical Scenarios
News | Clinical Decision Support | October 11, 2017
October 11, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the...
Overlay Init